Sinonasal undifferentiated carcinoma: Institutional trend toward induction chemotherapy followed by definitive chemoradiation
- 18 July 2020
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 42 (11) , 3197-3205
Abstract
Background: Recent reports have investigated the nascent role of induction chemotherapy for sinonasal undifferentiated carcinoma (SNUC). The goal of this study was to ascertain trends in treatment pattern changes for SNUC at a single institution and design a treatment algorithm utilized at our institution.Methods: Retrospective chart analysis of 21 cases of SNUC from 2010 to 2018.Results: Of 21 patients in this cohort, 18 (85.7%) presented with T4 disease, 7 (33.3%) presented with nodal disease, and 3 (14.3%) presented with distant metastasis. Since 2016, patients have been managed by induction chemotherapy followed by concurrent chemoradiation. To this point, patients treated with TPF induction chemotherapy followed by concurrent chemoradiation show no evidence of disease; however, the average follow up time is 16.8 months.Conclusions: The multimodality treatment for SNUC continues to evolve, as highlighted by this study, toward increased use of induction chemotherapy followed by chemoradiotherapy.Keywords
This publication has 19 references indexed in Scilit:
- Role of 18F‐FDG PET/CT differentiating olfactory neuroblastoma from sinonasal undifferentiated carcinomaThe Laryngoscope, 2016
- Current management of sinonasal undifferentiated carcinomaRhinology journal, 2015
- Treatment outcomes and prognostic factors, including human papillomavirus, for sinonasal undifferentiated carcinoma: A retrospective reviewHead & Neck, 2014
- Improved clinical outcomes with multi-modality therapy for sinonasal undifferentiated carcinoma of the head and neckAmerican Journal of Otolaryngology, 2013
- Combined-modality treatment improved outcome in sinonasal undifferentiated carcinoma: single-institutional experience of 21 patients and review of the literatureEuropean Archives of Oto-Rhino-Laryngology, 2012
- Randomized Trial of Induction Chemotherapy With Cisplatin and 5-Fluorouracil With or Without Docetaxel for Larynx PreservationJNCI: Journal of the National Cancer Institute, 2009
- Management of sinonasal undifferentiated carcinomaHead & Neck, 2008
- Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck CancerNew England Journal of Medicine, 2007
- Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck CancerNew England Journal of Medicine, 2007
- Sinonasal Undifferentiated Carcinoma: The Search for a Better OutcomeThe Laryngoscope, 2002